Baird Financial Group, Inc. Procept Bio Robotics Corp Transaction History
Baird Financial Group, Inc.
- $50.2 Billion
- Q3 2024
A detailed history of Baird Financial Group, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Baird Financial Group, Inc. holds 38,910 shares of PRCT stock, worth $2.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
38,910
Previous 45,509
14.5%
Holding current value
$2.66 Million
Previous $2.78 Million
12.12%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
271Shares Held
38.7MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA4.84MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$238 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$105 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$85.1 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$80.7 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.05B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...